Potassium iodide IOSAT 130 mg Potassium Iodide Tablets
Potassium iodide IOSAT 130 mg Potassium Iodide Tablets
- 5 Packs of 14 tablets each equal to 70 tablets
- 130 mg Potassium Iodide per tablet
- One dose every 24 hours for no more than 10 days
- Reduces chance of thyroid damage in a radiation emergency
Meets all FDA requirements for potassium iodide as a radiation
protective, and is labeled and packaged in accordance with US government
guidelines. Has demonstrated all quality controls and passed all FDA
requirements for purity, quality, safety, efficacy. Comes full strength
(130 mg of potassium iodide per tablet) in accordance with FDA demands
for complete thyroid blocking. Contains no potassium iodate or other
adulterants. Contains only pure potassium iodide as the active
ingredient. iOSAT [potassium iodide] is manufactured in the United
States under strict FDA "GMP guidelines," and holds an approved "New
Drug Application" (NDA). iOSAT [potassium iodide] was the first product
of its kind (since 1982) and is the only product which can be purchased
by local, state and federal governments. Is widely purchased by nuclear
utilities. iOSAT [potassium iodide] offers unit dose packaging for
maximum shelf-life and allows for individual tablet distribution without
fear of loss of packaging integrity.
Potassium iodide IOSAT 130 mg Potassium Iodide Tablets
